Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Entheon Biomedical Corp (ENBI.CN)

Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Entheon Announces Execution of Business Combination Agreement with Nutravisor

Toronto, Ontario--(Newsfile Corp. - January 19, 2026) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered into a definitive...

ENBI.CN : 0.1000 (unch)
ENTBF : 0.0794 (+2.98%)
Entheon Announces Letter of Intent with Nutravisor Inc.

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered...

ENBI.CN : 0.1000 (unch)
ENTBF : 0.0794 (+2.98%)
Upcoming Meeting Dates - October 20, 2025

Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies...

ENBI.CN : 0.1000 (unch)
RV.VN : 0.050 (-9.09%)
SILV.VN : 0.275 (-3.51%)
FMM.VN : 0.065 (+30.00%)
ATHR.CN : 0.0300 (unch)
AJN.CN : 0.2300 (unch)
CTTT.CN : 0.5000 (+13.64%)
AUEN.VN : 0.335 (+6.35%)
SVE.VN : 0.620 (+6.90%)
LA.VN : 12.250 (-4.15%)
BIRD.VN : 0.080 (unch)
CMC.VN : 0.065 (unch)
Entheon Announces Change of Directors

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces the appointment of Harrison Newlands...

ENBI.CN : 0.1000 (unch)
ENTBF : 0.0794 (+2.98%)
Entheon Issues Incentive Stock Options

Vancouver, British Columbia--(Newsfile Corp. - March 31, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that the Company has granted options...

ENBI.CN : 0.1000 (unch)
ENTBF : 0.0794 (+2.98%)
Entheon Announces Termination of Mentis AI Agreement

Vancouver, British Columbia--(Newsfile Corp. - March 14, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that, further to its news release...

ENBI.CN : 0.1000 (unch)
ENTBF : 0.0794 (+2.98%)
Entheon Announces Agreement to Acquire Mentis AI

Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered...

ENBI.CN : 0.1000 (unch)
ENTBF : 0.0794 (+2.98%)
Cybin (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate CYB004 Clinical Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition...

ENBI.CN : 0.1000 (unch)
CYBN.NE : 11.5800 (+4.23%)
CYBN : 8.28 (+1.22%)
ENTBF : 0.0794 (+2.98%)
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders

Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam...

ENBI.CN : 0.1000 (unch)
CMPS : 6.58 (-2.88%)
CYBN.NE : 11.5800 (+4.23%)
ATAI : 3.39 (-4.24%)
FTRP : 0.8421 (+1.07%)
CYBN : 8.28 (+1.22%)
FTRP.TO : 1.09 (+5.83%)
ENTBF : 0.0794 (+2.98%)
SILO : 0.3277 (-6.37%)
Cybin (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that, through its wholly-owned subsidiary Cybin IRL Limited,...

ENBI.CN : 0.1000 (unch)
CYBN.NE : 11.5800 (+4.23%)
CYBN : 8.28 (+1.22%)
ENTBF : 0.0794 (+2.98%)

Barchart Exclusives

Iran War, CPI and Other Key Thing to Watch this Week
Markets enter a critical week following last week's February jobs report that showed the U.S. economy lost around 92,000 jobs, which was a dramatic miss that has intensified recession concerns and raised questions about economic resilience amid escalating geopolitical tensions. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar